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INTRODUCTION
Twenty years ago, President Clinton signed the Health Insurance
Portability and Accountability Act of 1996 (HIPAA) into law. 1 Over the past
two decades, the federal Department of Health and Human Services (HHS) has
published several sets of rules 2 implementing the Administrative
Simplification provisions within HIPAA 3 as well as the Health Information
Technology for Economic and Clinical (HITECH) Act within the American
Recovery and Reinvestment Act (ARRA). 4 These rules include, but certainly
are not limited to, a final rule published on January 25, 2013, governing the use
and disclosure of protected health information by covered entities and their
business associates (the Privacy Rule). 5
Since 2003, I have been teaching one-, two-, and three-credit Privacy Rule
classes at law schools across the country. I also have provided continuing
education and other training programs on the topic of the Privacy Rule to
practicing physicians, dentists, clinical psychologists, social workers, nurses,
and other health care professionals, as well as non-lawyer privacy officials and
other health industry participants. My goal with this Article is to examine
approaches to teaching the Privacy Rule to law and non-law audiences.
Through trial and error, I believe I have improved my Privacy Rule teaching
since 2003, and I wish to share my pedagogical successes and failures in this
Article.
This Article proceeds as follows: Part I summarizes the history of the
Privacy Rule, including the many proposed rules, interim final rules, final
rules, guidance documents, and resolution agreements published by HHS. 6 Part
II reviews the Privacy Rule’s theory of and approach to health information
confidentiality. 7 Part III discusses my experience teaching the Privacy Rule to
both law and non-law audiences. 8
In part because few judicial opinions interpreting the Privacy Rule are
substantively helpful, Part III argues that Privacy Rule teachers may wish to

1. Health Insurance Portability and Accountability Act of 1996, Pub. L. No. 104-191, 110
Stat. 1936 [hereinafter HIPAA].
2. See infra notes 18–33 (referencing several sets of proposed, interim final, and final
rules).
3. HIPAA, Title II, Subtitle F, §§ 261–264 [hereinafter Administrative Simplification
Provisions].
4. See American Recovery and Reinvestment Act of 2009, Pub. L. No. 111-5, § 13001–
13424, 123 Stat. 115, 226–279 [hereinafter ARRA] (including the Health Information
Technology for Economic and Clinical Health (HITECH) Act).
5. Privacy of Individually Identifiable Health Information, 45 C.F.R. §§ 164.500–164.534,
Part 164, Subpart E (2016) [hereinafter Privacy Rule].
6. Infra Part I.
7. Infra Part II.
8. Infra Part III.
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teach fewer cases and focus instead on the principles of health information
confidentiality gleaned from the preambles to HHS’s rulemakings as well as
HHS’s guidance documents, resolution agreements, and frequently-asked
questions. 9 Part III further suggests that Privacy Rule teachers who train nonlaw audiences solicit questions in advance and use these questions to illustrate
the Privacy Rule’s use-and-disclosure requirements, as bird’s-eye legal
overviews tend to be unhelpful. 10
I. HISTORY OF THE PRIVACY RULE 11
As signed into law by President Clinton on August 21, 1996, HIPAA had
several purposes, including improving portability and continuity of health
insurance coverage in the individual and group markets, combating health care
fraud and abuse, promoting the use of medical savings accounts, improving
access to long-term care services and insurance coverage, and simplifying the
administration of health insurance. 12 The Administrative Simplification
Provisions, codified at Subtitle F of Title II of HIPAA, 13 directed HHS to issue
regulations protecting the privacy 14 of individually identifiable health

9. Infra Part III.
10. Infra Part III.
11. I have reviewed the history of and the regulatory approach taken in the Privacy Rule in a
number of prior scholarly articles. See, e.g., Stacey A. Tovino, Hospital Chaplaincy Under the
HIPAA Privacy Rule: Health Care or “Just Visiting the Sick?”, 2 IND. HEALTH L. REV. 51
(2005); STACEY A. TOVINO, Medical Privacy, in GOVERNING AMERICA: MAJOR DECISIONS OF
FEDERAL, STATE, AND LOCAL GOVERNMENTS FROM 1789 TO THE PRESENT 644 (Paul J. Quirk &
William Cunion eds. 2011); Stacey A. Tovino, HIPAA Privacy for Physicians, 17 PATHOLOGY
CASE REV. 160 (2012); Stacey A. Tovino, Gone Too Far: Federal Regulation of Health Care
Attorneys, 91 OR. L. REV. 813 (2013); Stacey A. Tovino, Silence Is Golden . . . Except in Health
Care Philanthropy, 48 U. RICH. L. REV. 1157 (2014); Stacey A. Tovino, Complying with the
HIPAA Privacy Rule: Problems and Perspectives, 1 LOYOLA U. CHI. J. REG. COMPLIANCE 23
(2016). With technical and conforming changes, much of Parts I and II of this Article are
reprinted from these prior scholarly articles with my permission.
12. See HIPAA, Pub. L. No. 104-191, Preface, 110 Stat. 1936, 1936 (“An Act [t]o amend the
Internal Revenue Code of 1986 to improve portability and continuity of health insurance coverage
in the group and individual markets, to combat waste, fraud, and abuse in health insurance and
health care delivery, to promote the use of medical savings accounts, to improve access to longterm care services and coverage, to simplify the administration of health insurance, and for other
purposes.”).
13. See Administrative Simplification Provisions, supra note 3.
14. Elsewhere, I defined and distinguished the concepts of privacy and confidentiality for
purposes of discussions addressing the legal responsibilities of health industry participants. See,
e.g., Stacey A. Tovino, Functional Neuroimaging Information: A Case for Neuro
Exceptionalism?, 34 FLA. ST. U. L. REV. 415, at Parts III(J), IV, and V (2007). This Article uses
the same definitions and distinctions. Privacy refers to an individual’s interest in avoiding the
unwanted collection by a third party of health or other information about the individual. Id. at
442. Confidentiality, on the other hand, refers to the obligation of a health industry participant to
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information if Congress failed to enact comprehensive privacy legislation
within three years of HIPAA’s enactment. 15 When Congress failed to enact
privacy legislation by its deadline, HHS incurred the duty to adopt privacy
regulations. 16 The original HIPAA statute clarified, however, that any privacy
regulations adopted by HHS must be made applicable only to three classes of
individuals and institutions: (1) health plans; (2) health care clearinghouses;
and (3) health care providers who transmit health information in electronic
form in connection with certain standard transactions (collectively, covered
entities). 17
HHS responded. On November 3, 1999, 18 and December 28, 2000, 19 HHS
issued a proposed and final privacy rule regulating covered entities’ uses and
disclosures of protected health information (PHI). On March 27, 2002, 20 and
August 14, 2002, 21 HHS issued proposed and final modifications to the
Privacy Rule. With the exception of technical corrections and conforming

prevent the unauthorized or otherwise inappropriate use or disclosure of voluntarily given and
appropriately gathered health and other information relating to an individual. Id. Although the
Privacy Rule actually is a health information confidentiality rule—because it sets limits on how
health care providers and other covered entities can use and disclose appropriately gathered
PHI—I use the phrase “Privacy Rule” and the word “privacy” in this Article because these are the
phrases and words selected by HHS and used by the public for the rule and the concepts
addressed therein. See, e.g., The HIPAA Privacy Rule, U.S. DEP’T HEALTH & HUMAN SERVS.,
https://www.hhs.gov/hipaa/for-professionals/privacy/ [https://perma.cc/XNM4-TFRM].
15. See Administrative Simplification Provisions, supra note 3, at § 264 (“If legislation
governing standards with respect to the privacy of individually identifiable health information . . .
is not enacted by the date that is 36 months after the date of the enactment of this Act, the
Secretary of Health and Human Services shall promulgate final regulations containing such
standards . . . .”).
16. See id.
17. § 262(a) (“Any standard adopted under this part shall apply, in whole or in part, to the
following persons: (1) A health plan. (2) A health care clearinghouse. (3) A health care provider
who transmits any health information in electronic form in connection with a transaction referred
to in section 1173(a)(1).”). See generally Standards for Privacy of Individually Identifiable Health
Information, 64 Fed. Reg. 59,918, 59,924 (proposed Nov. 3, 1999) [hereinafter 1999 Proposed
Rule] (explaining that HHS did not directly regulate any entity that was not a covered entity
because it did not have the statutory authority to do so).
18. 1999 Proposed Rule, supra note 17, at 59,918.
19. Standards for Privacy of Individually Identifiable Health Information, 65 Fed. Reg.
82,462 (Dec. 28, 2000) (codified at 45 C.F.R. pt. 160–164) [hereinafter 2000 Final Rule].
20. Standards for Privacy of Individually Identifiable Health Information, 67 Fed. Reg.
14,776 (Mar. 27, 2002) (codified at 45 C.F.R. pt. 160–164).
21. Standards for Privacy of Individually Identifiable Health Information, 67 Fed. Reg.
53,182 (Aug. 14, 2002) (codified at 45 C.F.R. pt. 160–164) [hereinafter 2002 Final
Modifications].
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amendments, 22 these rules as reconciled remained largely unchanged between
2002 and 2009.
The nature and scope of the legal duties of confidentiality that applied to
covered entities and their business associates (BAs) 23 changed significantly
more than eight years ago. On February 17, 2009, President Obama signed
ARRA into law. 24 Division A, Title XIII of ARRA, better known as HITECH,
contained certain provisions requiring HHS to modify some of the information
use and disclosure requirements and definitions set forth in the Privacy Rule,
adopt new breach notification rules, and amend the civil penalty amounts that
may be imposed on covered entities and BAs who violate the Privacy Rule. 25
Since ARRA’s enactment, HHS has issued several sets of proposed rules,
interim final rules, final rules, and technical corrections both implementing
HITECH’s required changes to the Privacy Rule as well as responding to other
national health information confidentiality concerns. On August 24, 2009, for
example, HHS released an interim final rule implementing HITECH’s new
breach notification requirements. 26 On October 30, 2009, HHS released an
interim final rule implementing HITECH’s strengthened enforcement
provisions, including strengthened civil monetary penalties that the federal
22. See, e.g., Standards for Privacy of Individually Identifiable Health Information,
Correction of Effective and Compliance Dates, 66 Fed. Reg. 12,434 (Feb. 26, 2001) (codified at
45 C.F.R. pt. 160–164); Technical Corrections to the Standards for Privacy of Individually
Identifiable Health Information Published December 28, 2000, 65 Fed. Reg. 82,944 (Dec. 29,
2000) (codified at 45 C.F.R. pt. 160–164) [hereinafter Technical Corrections I].
23. Business associates (BAs) are defined to include individual and institutions who: (1) on
behalf of a covered entity, but other than in the capacity of a member of the workforce of a
covered entity, create, receive, maintain, or transmit PHI for a function or activity regulated by
the HIPAA Privacy Rule; and (2) provide, other than in the capacity of a member of the
workforce of such covered entity, legal, actuarial, accounting, consulting, data aggregation,
management, administrative, accreditation, or financial services to or for the covered entity. See
Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules
under the Health Information Technology for Economic and Clinical Health Act and the Genetic
Information Nondiscrimination Act; Other Modifications to the HIPAA Rules, 78 Fed. Reg.
5566, 5688 (Jan. 25, 2013) (codified at 45 C.F.R. 160 and 164) (adopting 45 C.F.R. § 160.103
and providing a new definition of business associate) [hereinafter Final Regulations].
24. ARRA, supra note 4.
25. Id. Elsewhere, I critiqued HITECH’s imposition of confidentiality requirements directly
on BAs and proposed statutory and regulatory changes to HITECH and the HIPAA Privacy Rule,
respectively, that would except a class of BAs, including outside counsel, from the confidentiality
obligations imposed on other BAs. See Stacey A. Tovino, Gone Too Far: Federal Regulation of
Health Care Attorneys, 91 OR. L. REV. 813 (2013). Elsewhere, I also critiqued HITECH’s
loosening of the regulatory provision that governs covered entities’ uses and disclosures of
protected health information for fundraising purposes. See Stacey A. Tovino, Silence Is
Golden . . . Except in Health Care Philanthropy, 48 U. RICH. L. REV. 1157 (2014). This Article
builds on my earlier scholarship focusing on the Privacy Rule.
26. Breach Notification for Unsecured Protected Health Information, 74 Fed. Reg. 42,740
(Aug. 24, 2009) (codified at 45 C.F.R. pt. 160–164).
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Office for Civil Rights (OCR) may, for the first time since the enactment of the
HIPAA statute, impose directly on BAs who fail to maintain the confidentiality
of PHI. 27 On May 31, 2011, HHS released a proposed rule that would modify
the HIPAA Privacy Rule’s accounting of disclosures requirement. 28 On
January 25, 2013, HHS released a final rule modifying the HIPAA Privacy,
Security, Breach Notification, and Enforcement Rules in accordance with
HITECH (Final Regulations). 29 On June 7, 2013, HHS released technical
corrections to the Final Regulations. 30 On September 16, 2013, HHS released a
Model Notice of Privacy Practices designed to assist covered entities in
complying with the Final Regulations. 31 On February 6, 2014, HHS released a
final rule modifying the Privacy Rule to provide individuals with a right to
receive their laboratory test results directly from their testing laboratories. 32 On
January 6, 2016, HHS released a final rule modifying the Privacy Rule to
permit certain covered entities to disclose protected health information to the
National Instant Criminal Background Check System such as the identities of
individuals who are disqualified from shipping, transporting, possessing, or
receiving a firearm. 33 And, as of this writing, HHS is working on a notice of
proposed rulemaking (NPRM) that would allow civil money penalties and
settlements associated with Privacy Rule violations to be shared with harmed
individuals, as required by HITECH. 34
In addition to its proposed, interim final, and final rulemakings, HHS also
has made publicly available forty different resolution agreements. In these
agreements, covered entities resolve to comply with the Privacy Rule, report to
HHS regarding its compliance with the Privacy Rule, and/or pay a resolution

27. HIPAA Administrative Simplification: Enforcement, 74 Fed. Reg. 56,123 (Oct. 30,
2009) (codified at 45 C.F.R. pt. 160).
28. HIPAA Privacy Accounting of Disclosures under the Health Information Technology for
Economic and Clinical Health Act, 76 Fed. Reg. 31,426 (May 31, 2011) (codified at 45 C.F.R. pt.
164).
29. Final Regulations, supra note 23.
30. See Technical Corrections to the HIPAA Privacy, Security, and Enforcement Rules, 78
Fed. Reg. 32,464, 32,466 (June 7, 2013) (to be codified at 45 C.F.R. pt. 160–164) [hereinafter
Technical Corrections II].
31. Model Notices of Privacy Practices, U.S. DEP’T HEALTH & HUMAN SERVS.,
http://www.hhs.gov/hipaa/for-professionals/privacy/guidance/model-notices-privacy-practices/
[https://perma.cc/57PE-8958] [hereinafter Model Notice].
32. CLIA Program and HIPAA Privacy Rule; Patients’ Access to Test Reports, 79 Fed. Reg.
7290 (Feb. 6, 2014) (codified at 45 C.F.R. pt. 164).
33. Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule and the
National Instant Criminal Background Check System (NICS), 81 Fed. Reg. 382 (Jan. 6, 2016) (to
be codified at 45 C.F.R. pt. 164).
34. E-mail from Iliana Peters, U.S. Dep’t Health & Human Servs., to Stacey Tovino,
University of Nevada, Las Vegas (Sept. 26, 2016, 4:23 A.M. PT) (on file with author).
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amount. 35 In a recent resolution agreement released by HHS on September 23,
2016, HHS required Care New England Health System (CNE)—on behalf of
eight current covered entities that are under CNE’s common ownership or
control, including Woman & Infants Hospital of Rhode Island (WIH)—to pay
HHS $400,000 and complete a comprehensive correction active plan following
WIH’s loss of two unencrypted backup tapes containing electronic PHI. 36 In a
second recent resolution agreement, executed by HHS and New York
Presbyterian Hospital (Hospital) on April 19, 2016, HHS required the Hospital
to pay $2.2 million and complete a comprehensive corrective action plan
following the Hospital’s impermissible disclosure of protected health
information to the media as part of a reality television show, and the Hospital’s
failure to implement privacy-related safeguards. 37
II. THE PRIVACY RULE’S APPROACH TO HEALTH INFORMATION
CONFIDENTIALITY
A brief summary of the Privacy Rule’s theory and approach to health
information confidentiality is necessary before discussing how best to teach the
Privacy Rule to law and non-law audiences. The Privacy Rule strives to
balance the interest of individuals in maintaining the confidentiality of their
health information and the interest of society in obtaining, using, and
disclosing health information to carry out a variety of public and private
activities. 38 To this end, the Privacy Rule regulates covered entities’ and BAs’
uses of, disclosures of, and requests for individually identifiable health
information (IIHI) 39 to the extent such information does not constitute: (1) an

35. Resolution Agreements, U.S. DEP’T HEALTH & HUMAN SERVS., https://www.hhs.gov/hi
paa/for-professionals/compliance-enforcement/agreements/index.html [https://perma.cc/4TJ8-H7
7G].
36. See Resolution Agreement between U.S. Dep’t Health & Human Servs. and Care New
England Health Sys. (Sept. 23, 2016), http://www.hhs.gov/sites/default/files/9-14-16-wih-racap1.pdf [https://perma.cc/4KC5-2WRZ].
37. See Resolution Agreement between U.S. Dep’t Health & Human Servs. and New York
Presbyterian Hosp. (Apr. 19, 2016), http://www.hhs.gov/sites/default/files/NYP%20NYMed%20
RACAP%20April%202016%20%28508%29_0.pdf [https://perma.cc/V9FE-YV7R] [hereinafter
New York Presbyterian Hospital Resolution Agreement].
38. See 2000 Final Rule, supra note 19, at 82,464 (“The rule seeks to balance the needs of
the individual with the needs of the society.”); id. at 82,468 (“The task of society and its
government is to create a balance in which the individual’s needs and rights are balanced against
the needs and rights of society as a whole.”); id. at 82,472 (“The need to balance these competing
interests—the necessity of protecting privacy and the public interest in using identifiable health
information for vital public and private purposes—in a way that is also workable for the varied
stakeholders causes much of the complexity in the rule.”).
39. The Privacy Rule defines individually identifiable health information (IIHI) as
[I]information that is a subset of health information, including demographic information
collected from an individual, and: (1) Is created or received by a health care provider,
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education record protected under the Family Educational Rights and Privacy
Act of 1974 (FERPA); (2) a student treatment record excepted from protection
under FERPA; (3) an employment record held by a covered entity in its role as
an employer; or (4) individually identifiable health information regarding a
person who has been deceased for more than fifty years. 40 The name given by
the Privacy Rule to the subset of IIHI described in the previous sentence is
protected health information (PHI). 41
Before using or disclosing PHI, the Privacy Rule requires covered entities
and BAs to adhere to one of three different rules—sometimes called the useand-disclosure rules—depending on the purpose of the information use or
disclosure. 42 These rules reflect HHS’s desire to appropriately balance the
interest of individuals in maintaining the confidentiality of their PHI with a
wide range of societal interests in obtaining, using, or disclosing PHI, some of
which may have greater societal importance and value than others. 43
The first rule allows covered entities and BAs to use and disclose PHI with
no prior permission from the individual who is the subject of the PHI—but
only in certain situations. That is, covered entities may freely use and disclose
PHI without any form of prior permission in order to carry out their own
treatment, 44 payment, 45 and health care operations 46 activities, 47 as well as
certain public benefit activities. 48

health plan, employer, or health care clearinghouse; and (2) Relates to the past, present, or
future physical or mental health or condition of an individual; the provision of health care
to an individual; or the past, present, or future payment for the provision of health care to
an individual; and (i) That identifies the individual; or (ii) With respect to which there is a
reasonable basis to believe the information can be used to identify the individual.
45 C.F.R. § 160.103 (2016).
40. Id. (defining “protected health information”).
41. Id. (using the phrase “protected health information”).
42. §§ 164.502–164.514 (setting forth the use and disclosure requirements applicable to
covered entities and business associates).
43. See 2000 Final Rule, supra note 19, at 82,464 (“The rule seeks to balance the needs of
the individual with the needs of the society.”); id. at 82,468 (“The task of society and its
government is to create a balance in which the individual’s needs and rights are balanced against
the needs and rights of society as a whole.”); id. at 82,472 (“The need to balance these competing
interests—the necessity of protecting privacy and the public interest in using identifiable health
information for vital public and private purposes—in a way that is also workable for the varied
stakeholders causes much of the complexity in the rule.”).
44. The Privacy Rule defines treatment as:
[T]he provision, coordination, or management of health care and related services by one
or more health care providers, including the coordination or management of health care by
a health care provider with a third party; consultation between health care providers
relating to a patient; or the referral of a patient for health care from one health care
provider to another.
45 C.F.R. § 164.501 (2016).
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As an example of this first rule, a covered general practitioner (GP) who
wishes to consult with a specialist in order to treat a patient may disclose PHI
to the specialist and the Privacy Rule does not require the patient to give the
GP prior authorization for the disclosure. 49 Likewise, a covered hospital that
treats a patient may send a bill to the patient’s insurer to obtain payment for
hospital services rendered without the patient’s prior authorization. 50 Similarly,
a teaching physician employed by a covered academic medical center may
involve medical students, interns, residents, and fellows in patient care,
without prior authorization from the patients who are receiving such care, to
enable the students and residents to learn to practice medicine. 51 By still
further example, a covered entity that is required by state or other law to
disclose PHI to another individual or entity may do so without patient
authorization. 52 By final illustrative example, a covered entity may disclose a
patient’s PHI to a law enforcement officer in certain situations, including when
the covered entity suspects that the death of the patient may have resulted from
criminal conduct. 53 The theory behind these permitted information uses and
disclosures is that treating patients, allowing health care providers to obtain
45. The Privacy Rule defines payment as the activities “undertaken by a health plan to
obtain premiums or to determine or fulfill its responsibility for coverage and provision of benefits
under the health plan” as well as the activities of a “health care provider or health plan to obtain
or provide reimbursement for the provision of health care.” Id.
46. The Privacy Rule defines health care operations with respect to a list of activities that are
related to a covered entity’s covered functions. Id. (defining “health care operations”). These
activities include, but are not limited to, conducting quality assessment and improvement
activities, conducting training programs in which medical and other health care students learn to
practice health care under supervision, and arranging for the provision of legal services. See id.
47. § 164.506(c)(1) (permitting a covered entity to use or disclose PHI for its own treatment,
payment, or health care operations).
48. Covered entities may use and disclose PHI for twelve different public policy activities
without the prior written authorization of the individual who is the subject of the information. §
164.512(a)–(l). These public policy activities include, but are not limited to, uses and disclosures
required by law, uses and disclosures for public health activities, disclosures for law enforcement
activities, uses and disclosures for research, and disclosures for workers’ compensation activities.
See § 164.512(a), (c), (f), (i), (l) (2016).
49. § 164.501 (defining “treatment” to include “consultations between health care providers
relating to a patient”).
50. See id. (defining “payment” to include “the activities undertaken by a health care
provider . . . to obtain . . . reimbursement for the provision of health care”); § 164.506(c)(1)
(permitting a covered entity to disclose PHI for its own payment activities).
51. Id. (defining “health care operations” to include “conducting training programs in which
students, trainees, or practitioners in areas of health care learn under supervision to practice or
improve their skills as health care providers.”).
52. See § 164.512(a) (allowing covered entities to “use or disclose protected health
information to the extent that such use or disclosure is required by law and the use or disclosure
complies with and is limited to the relevant requirements of such law.”).
53. § 164.512(f)(4).
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reimbursement for providing health care, training medical students and
residents, complying with state law, and alerting law enforcement officers to
the suspicion of criminal activity outweigh an individual’s interest in
maintaining complete confidentiality of his or her PHI.
The first rule requires no prior authorization from the individual who is the
subject of the information before the information use or disclosure may occur.
Under the second rule, a covered entity may use and disclose an individual’s
PHI for certain activities, but only if the individual is informed in advance of
the use or disclosure and has the opportunity to agree to or prohibit or restrict
the use or disclosure. 54 Because the Privacy Rule allows the covered entity to
orally inform the individual of (and capture an oral agreement or oral objection
to) a use or disclosure permitted by these provisions, this second rule is
sometimes referred to as the “oral permission rule,” although a more practical
written permission also will suffice.
Under the second rule, a covered entity may conduct five sets of
information uses and disclosures once the individual who is the subject of the
information has been notified and has either agreed or not objected to the
information use or disclosure. 55 These five sets of information uses and
disclosures include: (1) certain uses and disclosures of directory information,
such as name, location, general condition, and religious affiliation; 56 (2) certain
uses and disclosures that would allow other persons to be involved in a
patient’s care or payment for care; 57 (3) certain uses and disclosures that would
help notify, or assist in the notification of, family members, personal
representatives, and other persons responsible for the care of the individual of
the individual’s location, general condition, or death; 58 (4) certain uses and
disclosures for disaster relief purposes; 59 and (5) certain disclosures to family
members and other persons who were involved in the individual’s care or
payment for health care prior to the individual’s death of PHI that is relevant to
that person’s involvement. 60
As an illustration of the second rule, the hospital room number and general
condition of a patient (e.g., ‘good,’ ‘fair,’ ‘poor,’ ‘stable’) who has given his or
her permission or who has not expressed an objection may be disclosed to a
visitor who requests directory information about that patient. 61 Likewise, a
woman in labor who wishes her partner to be present for her labor and delivery

54.
55.
56.
57.
58.
59.
60.
61.

§ 164.510.
Id.
§ 164.510(a).
§ 164.510(b)(1)(i).
§ 164.510(b)(1)(ii).
§ 164.510(b)(4).
§ 164.510(b)(5).
§ 164.510(a)(1), (2).
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may orally give her permission for her health care providers to involve her
partner in her care. 62
The theory behind requiring at least oral permission for these information
uses and disclosures is that the patient has an interest in maintaining the
confidentiality of his or her PHI; however, the patient also may have an
interest in being visited in the hospital, in obtaining assistance with the
patient’s health care or payment for health care, and being assisted during a
disaster. In addition, the patient’s family also may have an interest in visiting
the patient in the hospital, assisting the patient with his or her health care and
financial needs, and obtaining assistance during a disaster. The required oral
permission reflects the individual’s interest in maintaining the confidentiality
of his or her health information but the lack of a requirement for a formal
written authorization reflects HHS’s desire to make it easy for the individual to
ask for or agree to receive help.
The third rule—a default rule—requires covered entities and BAs to obtain
the prior written authorization of the individual who is the subject of the PHI
before using or disclosing the individual’s PHI in any situation that does not fit
under the first or second rule. Stated another way, in the event that a covered
entity or BA would like to use or disclose PHI for a purpose that is not
treatment, payment, or health care operations, that does not fall within one of
twelve public benefit exceptions, that is not allowed with oral permission or
without an objection, and that is not otherwise permitted or required by the
Privacy Rule, the covered entity must obtain the prior written authorization of
the individual who is the subject of the information. 63
The Privacy Rule specifies the form of the authorization required by the
third rule, including certain elements and statements that are designed to place
the individual on notice of how the individual’s PHI will be used or
disclosed. 64 This high level of prior individual permission reflects the value
HHS places on an individual’s interest in maintaining the confidentiality of his
or her PHI compared to other societal interests that are far removed from the
core functions of covered entities and BAs, such as a health care provider’s
interest in selling the patient’s information to a tabloid magazine or a health
plan’s interest in disclosing the patient’s information to a marketing company
to allow the company to market its products and services to the individual. 65

62. § 164.510(b)(1)(i).
63. § 164.508(a)(1).
64. § 164.508(c)(1)–(2).
65. See 2000 Final Rule, supra note 19, at 82,514 (“[C]overed entities must obtain the
individual’s authorization before using or disclosing protected health information for marketing
purposes.”).
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With this background regarding the Privacy Rule’s theory and approach to
health information confidentiality, Part III of this Article will discuss methods
of teaching the Privacy Rule to law and non-law audiences.
III. TEACHING THE PRIVACY RULE
A.

Teaching the Case Law

Since Fall 2003, I have taught a number of law courses based heavily in
the common law, including Torts. When teaching Torts, I focus almost
exclusively on the hundreds of cases made available by the authors of my
assigned casebook. 66 I think these cases are outstanding for helping students
understand the intentional torts, negligence, strict liability, products liability,
and other tort-based theories of liability, as well as their privileges and
defenses. Occasionally, I will supplement these cases with a Restatement
provision or a Nevada statute (since I teach at the University of Nevada, Las
Vegas), especially if the provision or statute is relevant to an issue under
discussion. For example, if I am discussing a case in which a plaintiff sues a
defendant for one tort but not a second tort because the statute of limitations
has already run on the second tort, I may ask the students to look up the
Nevada statute that sets forth the statute of limitations for the second tort.67
The vast majority of my Torts class discussions, however, focus on theories of
liability as well as privileges and defenses to the torts as they are presented in
federal and state judicial opinions.
When I first started teaching the Privacy Rule in Fall 2003, I was
uncomfortable because I was forced to teach straight from the final rule that
was published in the Federal Register on December 28, 2000, 68 as well as the
final modifications published in the Federal Register on August 14, 2002.69
Because most covered entities did not have to comply with the Privacy Rule
until April 14, 2003, 70 there were few published cases, other than statutory and
regulatory challenges, before then. 71 Even after April 14, 2003, it took cases

66. See VICTOR E. SCHWARTZ, KATHRYN KELLY & DAVID F. PARTLETT, PROSSER, WADE,
(13th ed. 2015).
67. NEV. REV. STAT. § 41A.097(2) (2016) (“[A]n action for injury or death against a
provider of health care may not be commenced more than 3 years after the date of injury or 1 year
after the plaintiff discovers or through the use of reasonable diligence should have discovered the
injury, whichever occurs first, for . . . professional negligence . . . .”).
68. See 2000 Final Rule, supra note 19, at 82,462.
69. Standards for Privacy of Individually Identifiable Health Information, 67 Fed. Reg.
53,182 (Aug. 14, 2002) (codified at 45 C.F.R. pt. 160–164).
70. See 45 C.F.R. § 164.534(a), (b)(1) (2016) (establishing an April 14, 2003 compliance
date for covered health care providers and non-small health plans).
71. See, e.g., S.C. Med. Ass’n v. Thompson, 327 F.3d 346, 351–55 (4th Cir. 2003)
(declaratory judgment action challenging HIPAA; holding that HIPAA did not impermissibly
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involving federal health information confidentiality issues a while to work
their way through the courts and to be published as judicial opinions. In
addition, because the Privacy Rule contains no private right of action, many of
the early judicial opinions simply clarified the lack of such right and dismissed
the plaintiffs’ claims on that basis. 72 Few substantively helpful judicial
opinions assessing the use-and-disclosure requirements codified at 45 C.F.R.
§§ 164.502–514, the individual rights provisions codified at 45 C.F.R. §§
164.520–528, the breach notification requirements codified at 45 C.F.R. §§
164.400–410, and the administrative requirements codified at 45 C.F.R. §
164.530 were available in the early 2000s for use in class discussions.
As courts began publishing opinions addressing substantive HIPAA
Privacy issues, I placed them in my syllabus in the appropriate place. Some of
these judicial opinions were helpful in clarifying issues that the Privacy Rule
itself did not answer.
For example, remember that the first use-and-disclosure rule discussed in
Part II allows covered entities and BAs to use and disclose PHI for their own
treatment, payment, and health care operations (TPO) activities without any
form of prior permission from the individual who is the subject of the PHI. 73
The regulation that allows these uses and disclosures74 is frequently referred to
as the “TPO rule.” Although the Privacy Rule defines the terms treatment,
payment, and health care operations, 75 these definitions do not answer every
single “Is this TPO?” question I receive from my students.
One illustrative question I have received more than once is whether
coerced, sometimes called assisted, treatment received by an individual who is

delegate legislative function, the Privacy Rule was not beyond scope of congressional grant of
authority, and that neither HIPAA nor the Privacy Rule was impermissibly vague); Ass’n Am.
Physicians & Surgeons, Inc. v. U.S. Dep’t Health & Human Servs., 224 F. Supp. 2d 1115, 1118,
1126–27 (S.D. Tex. 2002) (declaratory judgment action against HHS challenging the Privacy
Rule as beyond the legislative scope of HIPAA as unconstitutional; holding in part that the
Privacy Rule was within the scope of HIPAA).
72. See, e.g., Univ. of Colo. Hosp. Auth. v. Denver Publ’g Co., 340 F. Supp. 2d 1142, 1146
(D. Colo. 2004) (“Because I find no such statutory intent in HIPAA, I may not imply a private
right of action, and University Hospital’s claim under HIPAA should be dismissed.”); Agee v.
United States, 72 Fed. Cl. 284, 289–90 (Ct. Cl. 2006) (“Accordingly, this Court dismisses
Plaintiff’s claims concerning violations of HIPAA because the statute does not provide for a
private right of action against the Federal Government.”); Johnson v. Quander, 370 F. Supp. 2d
79, 100 (D.D.C. 2005) (“Here, the plaintiff challenges, pursuant to the HIPAA, the disclosure of
information regarding his DNA . . . [B]ecause no private right of action exists under the HIPAA,
this Court does not have subject matter jurisdiction over this claim and it must be dismissed.”).
73. 45 C.F.R. § 164.506(c)(1) (2016). See generally supra Part II (discussing the Privacy
Rule’s requirements relating to uses and disclosures of protected health information).
74. See § 164.506(c)(1).
75. See § 164.501 (2016) (defining “treatment,” “payment,” and “operations” for purposes
of the Privacy Rule).
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involuntarily committed under state law falls within the Privacy Rule’s
definition of treatment. If so, a covered entity, such as a covered hospital or
clinic, would be permitted to disclose medical records supporting the severity
of the individual’s mental health condition to a court that would be ruling on
the involuntary commitment or a subsequent involuntary health care provider.
The Privacy Rule does not address this issue. 76
However, in In re Miguel M., the New York Court of Appeals 77 held that
the purpose of the treatment rule is to facilitate the sharing of PHI among
health care providers working together, not the sharing of PHI by one
voluntary health care provider with a second, involuntary one. 78 The court
reasoned that, “[d]isclosure for that [involuntary] purpose is a more serious
invasion of privacy than, for example, the transmission of medical records
from a patient’s primary care physician to a specialist—the sort of activity for
which the treatment exception seems primarily designed. The treatment
exception is inapplicable here.” 79 I have included In re Miguel M. in my
Privacy Rule syllabus since its publication in 2011 because I can use it to
illustrate a disclosure of PHI that implicates the TPO rule, to help my students
understand the difference between voluntary and involuntary treatment, and to
teach the limitations of the otherwise broad range of PHI uses and disclosures
allowed under the TPO rule.
In re Miguel M. is substantively helpful for other reasons as well. Because
not all my HIPAA Privacy students have taken a course in Public Health Law
before enrolling in HIPAA Privacy, they may not understand the difference
between public health law, which focuses on legal measures that may help
identify, prevent, and ameliorate health risks of a community, 80 and private
health law, which focuses on legal authorities that help guide disputes between
individual physicians and patients, individual hospitals and particular medical
staff members, and health plans and in-network or out-of-network providers,
among other individual relationships. I have found that students who lack
exposure to principles of public health law frequently are unable to apply the
public health exception to the Privacy Rule, which allows covered entities to

76. See id. (defining “treatment” as the “provision, coordination, or management of health
care and related services by one or more health care providers, including the coordination or
management of health care by a health care provider with a third party; consultation between
health care providers relating to a patient; or the referral of a patient for health care from one
health care provider to another” but not clarifying whether the definition is limited to voluntary
treatment or whether involuntary treatment is included).
77. In re Miguel M., 17 N.Y.3d 37 (N.Y. 2011).
78. Id. at 43.
79. Id.
80. See, e.g., Lawrence O. Gostin, A Theory and Definition of Public Health Law, 10 J.
HEALTH CARE L. & POL’Y 1 (2007) (defining public health).
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disclose PHI to public health authorities for public health purposes without the
prior written authorization of the individuals who are the subject of the PHI. 81
In re Miguel M. is helpful for teaching students when the public health
exception to the Privacy Rule applies. In In re Miguel M., the physician who
was petitioning for Miguel’s involuntary commitment argued that the
disclosure of Miguel’s PHI would protect the public health because it would
help ensure that Miguel would be involuntarily committed and therefore would
not injure or kill anyone else, including members of the public. 82 The New
York Court of Appeals disagreed, reasoning that the purpose of the public
health exception was to “facilitate government activities that protect large
numbers of people from epidemics, environmental hazards, and the like, or that
advance public health by accumulating valuable statistical information.” 83 The
court found that the disclosure of PHI of one particular individual, such as
Miguel M., for the purpose of preventing that individual from harming himself
or others “effects a very substantial invasion of privacy without the sort of
generalized public benefit that would come from, for example, tracing the
course of an infectious disease.” 84 The court ultimately ruled that the
disclosure of Miguel’s PHI to the physician who was petitioning for Miguel’s
involuntary commitment did not come within the scope of the public health
exception. I love teaching this case because, in addition to the treatment
analysis discussed above, it kills two more birds. That is, it teaches students the
difference between public and private health and helps them identify situations
when the public health exception to the Privacy Rule does and does not apply.
Unlike In re Miguel M., however, many cases addressing Privacy Rule
issues interpret the Rule incorrectly, in my opinion, or pass on ruling on
Privacy Rule issues that the courts believe are too difficult to answer. For
example, many courts struggle with the most basic of Privacy Rule issues,
including determining whether a defendant is a covered entity to whom the
Privacy Rule applies. In In re National Hockey League Players’ Concussion
Injury Litigation, for example, the United States District Court for the District
of Minnesota was set to analyze whether the National Hockey League (NHL)
or any of its member teams were covered entities under the Privacy Rule. 85

81. See 45 C.F.R. § 164.512(b)(1) (2016) (“A covered entity may . . . disclose protected
health information . . . to . . . [a] public health authority that is authorized by law to collect or
receive such information for the purpose of preventing or controlling disease, injury, or disability,
including, but not limited to, the reporting of disease, injury, vital events such as birth or death,
and the conduct of public health surveillance, public health investigations, and public health
interventions . . . . ”).
82. In re Miguel M., 17 N.Y.3d at 42.
83. Id. at 42–43.
84. Id. at 43.
85. In re Nat’l Hockey League Players’ Concussion Injury Litig., 120 F. Supp. 3d 942, 953
(D. Minn. 2015) (referencing the question of whether the NHL is a covered entity).
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This analysis is simple and requires only asking the following: (1) Whether the
teams meet the definition of a health plan by making health insurance available
to their hockey players; 86 or (2) Whether the teams meet the definition of a
covered health care provider by making sports injury and other health care
available to the hockey players and subsequently electronically billing a public
or private health care program or plan for such care. 87
Instead of conducting this straightforward analysis, the court says: “It is
unclear whether the [hockey teams] are covered entities.” 88 I assigned this
opinion, published on July 31, 2015, to my Spring 2016 HIPAA Privacy
students because I thought the application of the Privacy Rule to a popular
professional sports league would be interesting to my sports- and
entertainment-obsessed law students. However, the court’s failure to rule on
the issue in which my students were most interested—the question of whether
NHL teams are covered entities—frustrated them. I will not include the
opinion in future syllabi.
B.

Teaching the HHS Guidance

In part because of the substantive weakness of much of the Privacy Rule
case law, I focus my law-based teaching instead on HHS guidance. This
guidance includes, but is certainly not limited to, preambles to all the proposed,
interim final, and final rulemakings; 89 separate, formal guidance documents
released by HHS on various aspects of the Privacy Rule; 90 hundreds of
answers to frequently-asked questions made available by HHS; 91 and dozens
of resolution agreements entered into by HHS and a variety of covered
entities. 92 I have found the HHS Guidance tremendously helpful in teaching
the Privacy Rule to law students. Allow me to provide a few examples of
teaching strategies using several different types of HHS Guidance.
The preambles to the proposed, interim final, and final rulemakings are
gems for teaching. Members of the public ask questions about the application

86. 45 C.F.R. § 160.103 (2016) (defining health plan).
87. Id. (defining health care provider; defining covered entity).
88. In re Nat’l Hockey League, 120 F. Supp. 3d at 953.
89. See, e.g., supra notes 18–32 (referencing all the proposed, interim final, and final rules
implementing section 264 of the HIPAA statute).
90. See Guidance on Significant Aspects of the Privacy Rule, U.S. DEP’T HEALTH & HUMAN
SERVS., http://www.hhs.gov/hipaa/for-professionals/privacy/guidance/significant-aspects/in
dex.html [https://perma.cc/TJN3-RGME] (providing guidance on seventeen different aspects of
the Privacy Rule).
91. HIPAA FAQs for Professionals, U.S. DEP’T HEALTH & HUMAN SERVS., http://www.hhs.
gov/hipaa/for-professionals/faq [https://perma.cc/XM2H-VKBM] (providing answers to hundreds
of frequently-asked questions in dozens of categories).
92. Resolution Agreements, supra note 35 (listing resolution agreements entered into by and
between HHS and covered entities starting in July 2008).
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of the Privacy Rule that are very similar to the types of questions asked by law
students, and HHS responds with its interpretation. I frequently assign my law
students portions of the various preambles as reading and ask them questions
in class based on HHS’s interpretations in these preambles. I do this for two
reasons. First, the preambles nicely illustrate the notice-and-comment
rulemaking process and allow the students to learn the procedure of
administrative law while they are learning the substance of the Privacy Rule.
Second, I want to encourage students to consult the preamble for HHS
interpretations before issuing their own, unverified Privacy Rule interpretations
to clients. As I will show using two examples below, HHS’s regulations are
frequently unclear and the agency’s interpretations are not always expected.
These two examples follow.
First, the Privacy Rule allows covered health care providers to use and
disclose PHI for their own treatment activities. 93 The Privacy Rule defines a
health care provider, in relevant part, as “any other person or organization who
furnishes, bills, or is paid for health care in the normal course of business.” 94
The Privacy Rule further defines health care as:
[C]are, services, or supplies . . . related to the health of the individual . . .
[including but not limited to]: (1) Preventive, diagnostic, therapeutic,
rehabilitative, maintenance, or palliative care; counseling; service; or
procedure with respect to the physical or mental condition, or functional status,
of an individual or that affects the structure or function of the body; and (2)
Sale or dispensing of a drug, device, equipment, or other item in accordance
95
with a prescription.

One question frequently asked by my students is whether a rabbi, priest, or
other clergy person who provides religious or spiritual counseling or services
at the hospital bedside is a health care provider, especially in the context of
religious patients whose mental (and arguably physical) health depend on their
faith. My students almost uniformly use their interpretive skills to answer this
question in the affirmative based on the presence of the word counseling
relative to a patient’s mental condition in the definition of health care and the
fact that many hospitals employ hospital chaplains and expressly list these
chaplains as members of the health care team on the hospitals’ websites. 96 A
quick search for the word “religious” in the preamble to the Privacy Rule
reveals a different interpretation by HHS, however:

93. 45 C.F.R. § 164.506(c)(1) (2016).
94. § 160.103 (italicized emphasis added) (defining health care provider).
95. Id. (italicized emphasis added) (defining health care).
96. See, e.g., Your Healthcare Team, CONFLUENCE HEALTH, https://www.confluencehealth.
org/patient-information/your-hospital-stay/healthcare-team/ [https://perma.cc/TFG9-UEWM]
(including “chaplain” in the list of “[p]atient care team members”).
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Also, in response to the comment regarding religious practitioners, the
Department clarifies that “health care” as defined under the rule does not
include methods of healing that are solely spiritual. Therefore, clergy or other
religious practitioners that provide solely religious healing services are not
health care providers within the meaning of this rule, and consequently not
97
covered entities for the purposes of this rule.

If my students had relied on their interpretations (when in practice), they would
have advised their clients incorrectly, perhaps encouraging a Privacy Rule
violation. I use this example to encourage my students to always check the
preamble for answers before relying on their own reasonable interpretations. I
also use this example to show how quickly word searches can be conducted
within the preamble to yield correct answers.
A second example relates to the status of organ procurement organizations
(OPOs) under the Privacy Rule. I used to represent a number of OPOs in a
variety of civil, regulatory, and transactional matters. When the Privacy Rule’s
April 14, 2003, compliance date neared, several of my OPO clients asked me
whether they were covered health care providers that were required to comply
with the Privacy Rule. Given that my OPO clients evaluated and procured
deceased-donor organs for transplantation, a reasonable legal interpretation of
the definition of health care provider 98 might be that OPOs provide therapeutic
services. In particular, they are responsible for matching organs to patients who
need organs based on donor blood type, height, weight, and other medical
factors, as well as proximity to the donor hospital, 99 and helping make those
organs available for transplantation. However, a quick search for the phrase
“organ procurement organization” within the preamble reveals a different
interpretation by HHS:
Comment: Some commenters suggested that blood centers and plasma donor
centers that collect and distribute source plasma not be considered covered
health care providers because the centers do not provide “health care services”
and the blood donors are not “patients” seeking health care. Similarly,
commenters expressed concern that organ procurement organizations might be
considered health care providers.
Response: We agree and have deleted from the definition of “health care” the
term “procurement or banking of blood, sperm, organs, or any other tissue for
administration to patients.”

I use this example, again, to encourage my students to check the preamble
before relying on their own Privacy Rule interpretations.

97. See 2000 Final Rule, supra note 19, at 82,568.
98. See text accompanying supra note 94 (defining health care provider).
99. See, e.g., How Organs Are Matched, UNITED NETWORK FOR ORGAN SHARING,
https://www.unos.org/transplantation/matching-organs/ [https://perma.cc/6SFW-XJ6Q]
(describing the ways in which OPOs help facilitate organ transplantation).
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A second source of HHS guidance is the formal guidance documents
published by HHS on a wide variety of topics. 100 These guidance documents
are invaluable for teaching the tricky use-and-disclosure requirements to law
students. The regulation codified at 45 C.F.R. § 164.506(c)(4) nicely illustrates
this point. Although the Privacy Rule allows covered entities to freely use and
disclose PHI to carry out their own TPO under 45 C.F.R. § 164.506(c)(1), the
Privacy Rule strictly regulates covered entities’ disclosures of PHI to other
individuals and institutions for the recipients’ health care operations (HCO)
activities under 45 C.F.R. § 164.506(c)(4). Under this regulation, a covered
entity may disclose PHI for another individual’s or entity’s HCO without the
prior authorization of the individual who is the subject of the PHI, but only if
four requirements have been satisfied: (1) the recipient individual or entity also
is a covered entity; (2) both the sending and receiving covered entities have
had in the past or have now a relationship with the individual who is the
subject of the PHI to be disclosed; (3) the PHI to be disclosed pertains to that
relationship; (4) the purpose of the disclosure is listed in the first or second
paragraph of the definition of HCO 101 or is a health care fraud and abuse
detection or compliance activity. 102
Ensuring student comprehension of this regulation is difficult, in part
because no judicial opinion provides an example of a disclosure that is, or is
not, permitted by this regulation. However, HHS has released a guidance
document titled “Uses and Disclosures for Treatment, Payment, and Health
Care Operations” that provides an example of a permissible disclosure: “A
health care provider may disclose protected health information to a health plan
for the plan’s Health Plan Employer Data and Information Set (HEDIS)
purposes, provided that the health plan has or had a relationship with the
individual who is the subject of the information.” 103 When students ask me to
provide a clear example of a disclosure permitted by 45 C.F.R. §
164.506(c)(4), I point them to this guidance document. After reading the

100. See supra note 90 (referencing the guidance documents published by HHS on a variety
of Privacy Rule topics).
101. The definition of health care operations contains six long paragraphs, some of which
have numerous clauses and/or sub-parts. See 45 C.F.R. § 164.501 (2016) (defining health care
operations). The first and second paragraphs of the definition include activities relating to quality
assessment and improvement, reviewing the competence or qualifications of health care
professionals, licensing, certification, accreditation, training of health care professionals, and
training of non-health care professionals. The third through sixth paragraph of the definition
include activities such as underwriting, legal services, business planning and development,
fundraising, and creating de-identified health information. See id.
102. 45 C.F.R. § 164.506(c)(4) (2016).
103. Uses and Disclosures for Treatment, Payment, and Health Care Operations, U.S. DEP’T
HEALTH & HUMAN SERVS., http://www.hhs.gov/sites/default/files/ocr/privacy/hipaa/understand
ing/coveredentities/sharingfortpo.pdf [https://perma.cc/6CU7-C4SP] (providing this example).
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guidance document, the students typically report how helpful it is, especially
because it provides other examples of PHI uses and disclosures that may (or
may not) be made under all the different paragraphs within 45 C.F.R. §
164.506. The students also report that this particular guidance document reads
like an Examples and Explanations (E&E) resource, 104 which they find helpful
for studying first-year and Bar subjects.
HHS’s formal guidance documents are helpful in other contexts as well.
The Privacy Rule’s marketing provisions, for example, are quite complex, and
my students frequently ask me to provide examples of communications that
meet the definition of marketing and, for those that do, communications that
require prior written authorization. As background, in one of the many sets of
definitions within the Administrative Simplification Rules, 105 HHS defines
marketing as “a communication about a product or service that encourages
recipients of the communication to purchase or use the product or service.” 106
However, HHS excepts from the definition of marketing communications that
are made:
(i) To provide refill reminders or otherwise communicate about a drug or
biologic that is currently being prescribed for the individual, only if any
financial remuneration received by the covered entity in exchange for making
the communication is reasonably related to the covered entity’s cost of making
the communication. (ii) For the following treatment and health care operations
purposes, except where the covered entity receives financial remuneration in
exchange for making the communication: (A) For treatment of an individual
by a health care provider, including case management or care coordination for
the individual, or to direct or recommend alternative treatments, therapies,
health care providers, or settings of care to the individual; (B) To describe a
health-related product or service (or payment for such product or service) that
is provided by, or included in a plan of benefits of, the covered entity making
the communication, including communications about: the entities participating
in a health care provider network or health plan network; replacement of, or
enhancements to, a health plan; and health-related products or services
available only to a health plan enrollee that add value to, but are not part of, a
plan of benefits; or (C) For case management or care coordination, contacting
of individuals with information about treatment alternatives, and related

104. See Examples & Explanations, WOLTERS KLUWER, http://www.wklegaledu.com/series/
examples-explanations [https://perma.cc/P572-Z3N9] (providing information regarding the
popular E&E series).
105. HHS codified definitions applicable to the Administrative Simplification Rules (Rules)
in several different places throughout the Rules, including 45 C.F.R. §§ 160.103, 160.202,
160.401, 160.502, 162.103, 164.103, 164.304, 164.402, 164.501 (2016).
106. See 45 C.F.R. § 164.501 (2016) (defining marketing).

SAINT LOUIS UNIVERSITY SCHOOL OF LAW

2017]

TEACHING THE HIPAA PRIVACY RULE

489

functions to the extent these activities do not fall within the definition of
107
treatment.

The Privacy Rule generally requires a covered entity to obtain an
authorization from an individual before using or disclosing the individual’s
PHI for an activity that falls within the definition of marketing. And, if the
marketing activity involves financial remuneration, the Privacy Rule requires
the written authorization form to identify such remuneration. 108 However, the
Privacy Rule does not require a covered entity to obtain an authorization from
an individual before using or disclosing the individual’s PHI for marketing that
takes the form of a “face-to-face communication made by a covered entity to
an individual” or a “promotional gift of nominal value provided by the covered
entity.” 109
Practicing health care attorneys have written volumes about the confusing
nature of the Privacy Rule’s marketing provisions. 110 If practicing health care
attorneys struggle with the Privacy Rule’s marketing provisions, it is no
surprise that my law students do as well. However, HHS released a guidance
document devoted to marketing that walks students through each step of the
analysis; that is, (1) whether a communication meets the definition of
marketing or is excepted from the definition of marketing; and (2) for those
that meet the definition of marketing, whether a prior written authorization is
required or whether an exception to the authorization requirement exists. 111 In
addition to the straightforward two-step analysis, the guidance document also
provides plenty of real-world examples of communications that do and do not
fall within the definition of marketing as well as communications that do and

107. Id.
108. § 164.508(a)(3)(ii).
109. § 164.508(a)(3)(i).
110. See, e.g., Jay Hodes, The HIPAA Privacy Rule – What Is Often Confusing About Some of
the Requirements?, LINKEDIN (Aug. 19, 2015), https://www.linkedin.com/pulse/hipaa-privacyrule-what-often-confusing-some-jay-hodes [https://perma.cc/83RK-TRNB] (“Another confusing
area of the HIPAA Privacy Rule concerns marketing.”); Gerard Clum, HIPAA and the
“Marketing” Quandary, DYNAMIC CHIROPRACTIC (Mar. 10, 2003), http://www.dynamicchiro
practic.com/pdf_out/DynamicChiropractic.com-HIPAA-and-the-Marketing-Quandary-14868441
79.pdf [https://perma.cc/6PXW-5UTN] (“One of the more confusing aspects of HIPAA involves
the concept of ‘marketing,’ and your ability to use protected health information (PHI) for
marketing purposes.”); Peter D. Ricoy, Marketing Under the HIPAA Megarule: The Rule
Becomes Tighter, ABA HEALTH E-SOURCE (May 2013), http://www.americanbar.org/content/
newsletter/publications/aba_health_esource_home/aba_health_law_esource_1305_ricoy.html
[https://perma.cc/EGH6-Y4PA] (“By design, using an individual’s protected health information
(‘PHI’) for marketing purposes has never been easy under the HIPAA Privacy Rule.”).
111. Marketing, U.S. DEP’T HEALTH & HUMAN SERVS., 1, 1–4 (Apr. 3, 2003), http://www.hh
s.gov/sites/default/files/ocr/privacy/hipaa/understanding/coveredentities/marketing.pdf
[https://perma.cc/4GFU-97CY].
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do not require prior written authorization. 112 My students have reported
success in using HHS’s guidance on marketing to learn the Privacy Rule’s
marketing provisions.
In addition to the preamble language and the formal guidance documents,
another source of helpful teaching material includes HHS’s answers to the
hundreds of publicly-submitted, frequently-asked questions regarding the
Privacy Rule. 113 One question my students frequently ask me is whether
contracted researchers who conduct research on behalf of a covered entity fall
within the definition of a business associate of the covered entity due to the
performance of such research. The question is a good one because the Privacy
Rule defines a business associate to include persons who, with respect to a
covered entity but other than in the capacity of a workforce member of the
covered entity, “creates, receives, maintains, or transmits protected health
information for a function or activity regulated by . . . [the Privacy Rule]”). 114
The Privacy Rule heavily regulates research at 45 C.F.R. § 164.512(i). 115 A
reasonable, logical interpretation of the definition of business associate, then, is
that a contracted researcher who creates PHI while conducting research for the
covered entity is a business associate of the covered entity. However, HHS’s
answer to frequently-asked question number 239 provides a different
interpretation:
Question: Is a business associate contract required for a covered entity to
disclose protected health information to a researcher?
Answer: No. Disclosures from a covered entity to a researcher for research
purposes do not require a business associate contract, even in those instances
where the covered entity has hired the researcher to perform research on the
covered entity’s own behalf. A business associate agreement is required only
where a person or entity is conducting a function or activity regulated by the
Administrative Simplification Rules on behalf of a covered entity, such as
payment or health care operations, or providing one of the services listed in the
116
definition of “business associate” at 45 CFR 160.103.

A final, illustrative source of outstanding teaching material includes the
resolution agreements. HHS has entered into dozens of resolution agreements
with covered entities pursuant to which a covered entity accused by HHS of
violating the Privacy Rule agrees to perform certain obligations and make

112. Id. at 2–4.
113. HIPAA FAQs for Professionals, supra note 91.
114. 45 C.F.R. § 160.103 (2016) (emphasis added) (defining “business associate”).
115. § 164.512(i) (regulating “[u]ses and disclosures for research purposes”).
116. Is a Business Associate Contract Required for a Covered Entity to Disclose Protected
Health Information to a Researcher?, U.S. DEP’T HEALTH & HUMAN SERVS. (Dec. 19, 2002),
http://www.hhs.gov/hipaa/for-professionals/faq/239/is-a-business-associate-contract-required-fora-covered-entity-to-information-to-a-researcher/index.html [https://perma.cc/GWD2-2ACD].
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reports to HHS, generally for a period of three years, and to pay a fine to HHS.
These resolution agreements can be very instructive in terms of teaching
questions that are not specifically answered by the Privacy Rule.
One question that I frequently encountered in my practice—and about
which many students have asked over the years as well—is the question
whether a covered hospital is permitted to allow a film crew to film patients in
the emergency room in order to produce a reality television show that can
generate extra revenue for the hospital. Importantly, the camera men would
obtain the authorization of all filmed patients prior to releasing the final
television video to a network. As a conservative attorney, I always answered
my clients and my students in the negative based on my gut, which told me
that HHS would view this as an unauthorized disclosure of PHI (including the
patients’ faces and their emergent physical conditions) by the hospital to the
cameramen, although any subsequent disclosure of the film by the cameramen
to a television network certainly would be authorized. However, many of my
less conservative colleagues disagreed. Until recently, neither the Privacy Rule
nor any HHS guidance provided clear answers.
On April 19, 2016, however, OCR entered into a resolution agreement
(“Agreement”) with New York Presbyterian Hospital (“Hospital”) following
the Hospital’s unauthorized disclosure of two patients’ PHI to an ABC
television film crew (“ABC”). As background, the Hospital allowed ABC to
film one patient’s death and a second patient’s significant clinical distress
without the patients’ or their legal representatives’ prior written authorization
in violation of the default rule summarized in Part II of this Article 117 in order
to produce the “high stakes medicine” reality television show, NY Med. 118 In
its press release announcing the Agreement, OCR stated, “[The Hospital’s]
actions blatantly violate the HIPAA Rules, which were specifically designed to
prohibit the disclosure of individual’s PHI, including images, in circumstances
such as these.” 119 OCR further stated that the Hospital “failed to safeguard
protected health information and allowed ABC film crews virtually unfettered
access to its health care facility, effectively creating an environment where PHI
could not be protected from impermissible disclosure to the ABC film crew
and staff.” 120 In addition to agreeing to pay OCR $2.2 million, the Hospital
also executed a corrective action plan pursuant to which the Hospital agreed to
117. See text accompanying supra notes 63–65 for a summary of the default rule.
118. About NY Med, ABC, http://abc.go.com/shows/ny-med/about-the-show [https://perma.
cc/R9AE-4CKJ] (“Sometimes poignant and often uproarious, [NY Med] takes a deep dive into
high stakes medicine through the eyes of unforgettable characters . . . . ”).
119. Unauthorized Filming for “NY Med” Results in $2.2 Million Settlement with New York
Presbyterian Hospital, U.S. DEP’T HEALTH & HUMAN SERVS. (Apr. 21, 2016), http://www.hhs.
gov/about/news/2016/04/21/unauthorized-filming-ny-med-results-22-million-settlement-newyork-presbyterian-hospital.html [https://perma.cc/KJ6G-P8UZ].
120. Id.
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monitoring by OCR for a period of two years. 121 I assigned this resolution
agreement as reading in my Spring 2017 HIPAA Privacy class.
C. Teaching Non-Law Audiences
Parts III (A) and (B), above, discussed methods of teaching the Privacy
Rule to law students. I am frequently asked to teach physicians, dentists,
clinical psychologists, social workers, nurses, and other non-law professionals,
including Privacy officials and compliance officers, regarding their obligations
under the Privacy Rule. These presentations usually are one or two hours in
length and the attendees usually receive continuing ethics education (“CE”)
credit for attending. When I first started providing CEs on the Privacy Rule to
non-law-trained professionals, I would borrow PowerPoints I had created for
my law students. These PowerPoints typically included much background
regarding the Privacy Rule, including references to all the different proposed,
interim final, and final rulemakings. Being the detailed lawyer that I am, I
would carefully review the administrative history that led to the regulations
that are now codified at 45 C.F.R. § 164 and provide a bird’s-eye legal
overview of the different provisions in the HIPAA and HITECH statutes as
well as the Privacy Rule, including not only the use-and-disclosure
requirements, but also the individual rights, the breach notification
requirements, and the administrative requirements. During the short questionand-answer session after each presentation, I could tell by the questions that
the health care professionals were either uninterested in, or simply unable to
digest, my heavy-in-administrative-law lecture.
After one presentation that was particularly poorly received, I asked a
neurology residency program director who attended how I could improve
going forward. The residency program director said he had an idea; that is, he
would ask his residents to submit all their Privacy Rule questions to me in
advance. Then, I could devote my presentation time to the questions in which
they were interested, rather than the administrative topics in which I was
interested. We followed this plan shortly thereafter.
When I received the questions from the residency program director, I
realized they all focused on the Privacy Rule’s use-and-disclosure
requirements. I also realized that the questions focused almost exclusively on
the question whether PHI could be used or disclosed in a particular situation
with or without prior patient authorization. None of the questions related to the

121. New York Presbyterian Hospital Resolution Agreement, supra note 37, at 2, § 6 (“HHS
has agreed to accept, and NYP has agreed to pay HHS, the amount of $2,200,000 . . . . ”); id. at §
7 (“[The Hospital] has entered into and agrees to comply with the Corrective Action Plan
(‘CAP’) . . . . If [the Hospital] breaches the CAP, and fails to cure the breach as set forth in the
CAP, then [the Hospital] will be in breach of this Agreement and HHS will not be subject to the
Release . . . . ”).
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administrative history of the Privacy Rule, the personnel designations required
by the Privacy Rule, the policies and procedures required by the Privacy Rule,
the compliance dates for the Privacy Rule, or the possible civil and criminal
penalties for violations of the Privacy Rule.
I organized the questions I received in order of the use and disclosure
requirements codified at 45 C.F.R. §§ 164.502–514, with the TPO questions
early in the presentation and the public benefit disclosures later in the
presentation. Then, I opened my presentation by reviewing the three use-anddisclosure rules summarized in Part II of this Article. Finally, I answered each
question using one of those three rules. By the end of the CE program, the
physicians who attended understood the three-tiered approach to individual
permission and were able to answer their own Privacy Rule questions with
reference to the regulations codified at 45 C.F.R. §§164.502–514.
CONCLUSION
This Article has summarized the history of the Privacy Rule, reviewed the
Privacy Rule’s theory of and approach to health information confidentiality,
and discussed my experience teaching the Privacy Rule to both law and nonlaw audiences. In part because few judicial opinions interpreting the Privacy
Rule are substantively helpful, this Article suggests that Privacy Rule teachers
may wish to teach fewer cases and focus instead on the principles of health
information confidentiality gleaned from the preambles to HHS’s rulemakings
as well as HHS’s guidance documents, resolution agreements, and frequently
asked questions. This Article also suggests that Privacy Rule teachers who
train non-law audiences solicit questions in advance and use these questions to
illustrate the Privacy Rule’s use-and-disclosure requirements, as bird’s-eye
legal overviews tend to be unhelpful.
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